Enfinity Global Statement on CEO Carlos Domenech
MIAMI, April 2, 2025 /PRNewswire/ -- As stated in the press release issued by TerraForm Power Parent, LLC on April 1, 2025, via GlobeNewswire: "On January 20, 2025, a lawsuit filed in the United States District Court for the District of Maryland...
Heng Ren Partners Demands Sinovac Distribute $8.9 Billion in Cash to its Shareholders and Cause Reinstatement of Trading
BOSTON, March 20, 2025 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) ("Sinovac") shareholder Heng Ren Partners, LLC funds ("Heng Ren") today sent an open letter to Sinovac's shareholders outlining the significant and decisive action that...
KPM Analytics Secures Legal Victory in Trade Secret Misappropriation Case
Court awards $10M to KPM Analytics in Trade Secret Theft and Tortious Interference Case, Reinforcing Commitment to Innovation and Fair Competition. WESTBOROUGH, Mass., March 3, 2025 /PRNewswire/ -- KPM Analytics, a global leader in analytical...
Hedgehog Risk Secures Investment From SIG Insurance Holdings, LLC
Member of the Susquehanna International Group of Companies, a global quantitative trading and investment firm, takes a significant stake in one of the leading providers of specialist sports and prize insurance LONDON, Jan. 28, 2025 /PRNewswire/ --...
DASI, LLC appoints new President as it continues to drive growth and strengthen leadership in the Aviation Aftermarket
Industry veteran Mike Heaton takes the helm to accelerate innovation and further enhance DASI, LLC's market position MIAMI, Jan. 13, 2025 /PRNewswire/ -- DASI, LLC, a premier provider of aircraft inventory solutions, is pleased to announce the...
![Norgine submits Marketing Authorisation Application to the European Medicines Agency for eflornithine (difluoromethylornithine [DFMO]) in high-risk neuroblastoma](http://prnewswire.vietreader.com/thumb/190x300/2025-01/norgine-submits-marketing-authorisation-application-to-the-european-medicines-agency-for-eflornithine-difluoromethylornithine-dfmo-in-high-risk-neuroblastoma-1.jpg)
Norgine submits Marketing Authorisation Application to the European Medicines Agency for eflornithine (difluoromethylornithine [DFMO]) in high-risk neuroblastoma
Back to media releases Next media release LONDON, Jan. 7, 2025 /PRNewswire/ -- Norgine today announced that it completed its marketing authorisation application filing to European Medicines Agency (EMA) for eflornithine in high-risk neuroblastoma...
Designs For Health Inc. Held Liable For Infringement of Kaneka's Ubiquinol Patent
TOKYO, Dec. 25, 2024 /PRNewswire/ -- Kaneka has successfully defended its patent for stabilizing Ubiquinol. On December 20, 2024, Kaneka Corporation won its lawsuit against Designs for Health, Inc. and American River Nutrition, LLC for infringement...
Complete Genomics Adds Eurofins Clinical Enterprise, LLC to its Sequencing Service Provider Program
FRAMINGHAM, Mass., Dec. 17, 2024 /PRNewswire/ -- Complete Genomics, a San Jose, California based genomics tools manufacturer, today announced Framingham, Massachusetts based Eurofins Clinical Enterprise, LLC as the newest addition to its Sequencing...
CNFinance Announces Change of Auditor
GUANGZHOU, China, Dec. 6, 2024 /PRNewswire/ -- CNFinance Holdings Limited (NYSE: CNF) ("CNFinance" or the "Company"), a leading home equity loan service provider in China, today announced the dismissal of KPMG Huazhen LLP ("KPMG"), the Company's...
Autozi Internet Technology (Global) Ltd. Announces Waiver of IPO Lock-up Restriction for its Controlling Shareholder to Enable Share Transfer to Two Consulting Service Providers
BEIJING, Nov. 30, 2024 /PRNewswire/ -- Autozi Internet Technology (Global) Ltd. ("Autozi" or the "Company") (Nasdaq: AZI), one of the leading and fast-growing lifecycle automotive service providers in China, today announced that Qirun Investment...